Can high estrogenic signaling relative to progesterone contribute to premenstrual symptoms?

Fluctuations in ovarian hormones throughout the menstrual cycle profoundly impact both central nervous system signaling and peripheral fluid regulation. When estrogenic signaling is elevated relative to progesterone, the lack of compensatory balance can trigger a cascade of psychological and physical premenstrual symptoms.

Neurotransmission and Mood Regulation

• GABAergic disruption: Estradiol acts in a primarily excitatory capacity by enhancing glutamatergic transmission and reducing GABAergic tone. Conversely, progesterone metabolizes into allopregnanolone, a positive allosteric modulator of $\text{GABA}_\text{A}$ receptors that promotes calming, anxiolytic effects.
• Anxiety and sleep disturbance: A skewed estradiol-to-progesterone ratio impairs central GABAergic tone and increases neural excitability. During the late luteal phase, the rapid withdrawal of progesterone and allopregnanolone disrupts the GABAergic system and hypothalamic-pituitary-adrenal (HPA) axis, directly triggering premenstrual anxiety and sleep architecture disruption.

Fluid Dynamics and Weight Fluctuations

• RAAS pathway activation: Estrogen directly stimulates the renin-angiotensin-aldosterone system (RAAS), prompting increased aldosterone secretion and lowering the osmotic threshold for arginine vasopressin (AVP) release, which promotes sodium and water retention.
• Loss of progesterone counterbalance: Progesterone normally exerts natriuretic and diuretic actions to oppose this pathway. In states of relative estrogen dominance, unchecked RAAS activation drives extracellular fluid accumulation, resulting in peripheral edema, bloating, and cyclical weight fluctuations.

Bottom line

• Relative estrogen dominance impairs central GABAergic transmission and activates peripheral fluid-retention pathways, directly contributing to premenstrual anxiety, sleep disturbances, fluid retention, and cyclical weight fluctuations.